Compare CDMOs manufacturing inhalation products -- MDIs, DPIs, nebulizer solutions, and nasal sprays. Filter by device type, particle engineering capability, and scale.
264 companies listed
Inhalation product manufacturing combines pharmaceutical formulation with device engineering. The drug must be delivered as aerosol particles in the 1-5 micron range for deep lung deposition. Three main platforms exist: metered-dose inhalers (MDIs, propellant-based), dry powder inhalers (DPIs, breath-actuated), and nebulizer solutions/suspensions (converted to aerosol by the nebulizer device).
Particle engineering is the core competency. Micronization (jet milling), spray drying, and engineered particle technologies control the aerodynamic particle size that determines drug deposition in the lungs. CDMOs with in-house particle engineering capabilities can optimize the formulation-device interaction that ultimately determines clinical efficacy.
China
Apeloa Pharmaceutical is a pharmaceutical CDMO offering comprehensive services.
Australia
Australian ALKALOIDS Trading PTY LTD is a pharmaceutical CDMO offering comprehensive services.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Germany
BioSpring GmbH is a pharmaceutical CDMO offering comprehensive services.